4//SEC Filing
Tatsis Ourania 4
Accession 0000950170-24-078782
CIK 0001840574other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 7:45 AM ET
Size
5.5 KB
Accession
0000950170-24-078782
Insider Transaction Report
Form 4
Tatsis Ourania
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-26+267,541→ 267,541 totalExercise: $5.02Exp: 2034-06-25→ Common Stock (267,541 underlying)
Footnotes (1)
- [F1]This stock option was issued pursuant to the 2021 Stock Incentive Plan of Verve Therapeutics, Inc. in accordance with its director compensation program. The vesting commencement date of the option is the grant date. The shares of common stock underlying the option are scheduled to vest in equal monthly installments through June 26, 2027, subject to the Reporting Person's continued service as a director.
Documents
Issuer
Verve Therapeutics, Inc.
CIK 0001840574
Entity typeother
Related Parties
1- filerCIK 0001789815
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 7:45 AM ET
- Size
- 5.5 KB